Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:40821778

HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy.

Frontiers in immunology · 2025 doi:10.3389/fimmu.2025.1623675

Paper

partial

Experiment

partial

Data

partial

Analysis

absent

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:40821778
kind
science-record
content_hash
sha256:e234d5a4372b88f404311a019bfcd205525a4495f607cc208c3fdc4e78a88de6
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T10:25:52Z
updated_at
2026-11-01T14:01:46Z
generator object · 3 fields
name
corpus-assay-engine
converter
sep_to_sci_v1
source_package_schema
urn:bntrg:sep:1.0.0
paper object · 10 fields
state
partial
title
HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy.
doi
10.3389/fimmu.2025.1623675
pmid
40821778
authors
null
journal
Frontiers in immunology
year
2025
abstract
null
claims array · 1 item
[0] object · 6 fields
id
claim-1
statement
the headline numerical result the paper states for its main finding
kind
quantitative
state
complete
target object · 4 fields
value
21.6
unit
percent
tolerance
null
source
chars 1378-1500 of source sha256 670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:40821778
locator
chars 1378-1500 of source sha256 670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c
quote
The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall
gaps array · 2 items
[0]
abstract
[1]
authors
experiment object · 8 fields
state
partial
objective
the headline numerical result the paper states for its main finding
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate and its interval from the source
kind
other
state
complete
blocked_on
null
description
The number a replication must land on, and the sentence it came from.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:40821778
outputs array · 1 item
[0]
the published estimate, its unit and its interval
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data behind the published result
kind
data-preparation
state
blocked
blocked_on
data:not_downloaded
description
The published result cannot be recomputed without the data the paper analysed.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the analysis programme
kind
analysis
state
blocked
blocked_on
no owned computational capability is bound to this experiment
description
Re-run the paper's analysis on the source data and produce the registered result. | SEP input not carried into the asset list: materials:the source data behind the published result in pmid:40821778
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the registered result
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 3 items
[0]
step:obtain_source_data blocked on data:not_downloaded
[1]
step:run_analysis blocked on no owned computational capability is bound to this experiment
[2]
step:run_analysis input 'materials:the source data behind the published result in pmid:40821778' does not resolve to a declared asset
data object · 3 fields
state
partial
assets array · 2 items
[0] object · 15 fields
id
source:pmid:40821778
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3389/fimmu.2025.1623675
sha256
sha256:670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3389/fimmu.2025.1623675
version
null
note
Source read by the package builder: full_text.
structure object · 1 field
access_state
full_text
[1] object · 16 fields
id
asset:table:pmid:40821778:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:6339ba42bbb813ada8b6205800990e40a75b71c395a70157c0d26a996171d11e
bytes
1483
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[9]/table-wrap[1]#T1
version
null
note
Baseline characteristics.
structure object · 5 fields
pmcid
PMC12354535
section_index
9
section_title
Baseline characteristics
row_count
26
column_count
5
table object · 8 fields
label
Table 1
caption
Baseline characteristics.
rows array · 26 items
[0] array · 5 items
[0]
Characteristic
[1]
Total (n = 244)
[2]
IMPC (n = 38)
[3]
Non-IMPC (n = 206)
[4]
aP-value
[1] array · 5 items
[0]
Median age (year)
[1]
46 (25–74)
[2]
44 (25–66)
[3]
47 (25–74)
[4]
0.133
[2] array · 5 items
[0]
Age, n (%)
[1]
[2]
[3]
[4]
0.183
[3] array · 5 items
[0]
≤40
[1]
80 (32.8)
[2]
16 (42.1)
[3]
64 (31.1)
[4]
[4] array · 5 items
[0]
>40
[1]
164 (67.2)
[2]
22 (57.9)
[3]
142 (68.9)
[4]
[5] array · 5 items
[0]
Tumor size, n (%)
[1]
[2]
[3]
[4]
0.748
[6] array · 5 items
[0]
≤ 2 cm
[1]
20 (8.2)
[2]
2 (5.3)
[3]
18 (8.7)
[4]
[7] array · 5 items
[0]
> 2 cm
[1]
224 (91.8)
[2]
36 (94.7)
[3]
188 (91.3)
[4]
[8] array · 5 items
[0]
Lymph nodes, n (%)
[1]
[2]
[3]
[4]
0.406
[9] array · 5 items
[0]
Negative
[1]
12 (4.9)
[2]
3 (7.9)
[3]
9 (4.4)
[4]
[10] array · 5 items
[0]
Positive
[1]
232 (95.1)
[2]
35 (92.1)
[3]
197 (95.6)
[4]
[11] array · 5 items
[0]
Hormone receptor, n (%)
[1]
[2]
[3]
[4]
<0.05
[12] array · 5 items
[0]
Negative
[1]
90 (36.9)
[2]
11 (28.9)
[3]
79 (38.3)
[4]
[13] array · 5 items
[0]
Positive
[1]
154 (63.1)
[2]
27 (71.1)
[3]
127 (61.7)
[4]
[14] array · 5 items
[0]
Grade, n (%)
[1]
[2]
[3]
[4]
0.993
[15] array · 5 items
[0]
G1 + G2
[1]
135 (55.3)
[2]
21 (55.3)
[3]
114 (55.3)
[4]
[16] array · 5 items
[0]
G3
[1]
109 (44.7)
[2]
17 (44.7)
[3]
92 (44.7)
[4]
[17] array · 5 items
[0]
Ki-67, n (%)
[1]
[2]
[3]
[4]
0.254
[18] array · 5 items
[0]
≤30%
[1]
104 (42.6)
[2]
13 (34.2)
[3]
91 (44.2)
[4]
[19] array · 5 items
[0]
>30%
[1]
140 (57.4)
[2]
25 (65.8)
[3]
115 (55.8)
[4]
[20] array · 5 items
[0]
Neoadjuvant targeted therapy, n (%)
[1]
[2]
[3]
[4]
0.052
[21] array · 5 items
[0]
Trastuzumab
[1]
94 (38.5)
[2]
20 (52.6)
[3]
74 (35.9)
[4]
[22] array · 5 items
[0]
Trastuzumab + pertuzumab
[1]
150 (61.5)
[2]
18 (47.4)
[3]
132 (64.1)
[4]
[23] array · 1 item
[0]
Neoadjuvant chemotherapy, n (%)
[24] array · 5 items
[0]
AC-T
[1]
170 (69.7)
[2]
24 (63.2)
[3]
146 (70.9)
[4]
0.342
[25] array · 5 items
[0]
TCb
[1]
74 (30.3)
[2]
14 (35.8)
[3]
60 (29.1)
[4]
locator
section[9]/table-wrap[1]#T1
gaps array · 1 item
[0]
asset:source:pmid:40821778 not verified
analysis object · 4 fields
state
absent
methods array · 0 items
targets array · 0 items
gaps array · 2 items
[0]
method
[1]
targets
capability object · 3 fields
state
absent
requirements array · 0 items
gaps array · 1 item
[0]
capability
readiness object · 8 fields
state
partial
tier
null
blocked_on
null
axes object · 0 fields
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 2 items
[0]
source:pmid:40821778
[1]
asset:table:pmid:40821778:1
steps array · 1 item
[0]
read_published_estimate
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 1 item
[0]
xml
capabilities array · 0 items
data_gaps array · 1 item
[0]
source:pmid:40821778
gaps array · 1 item
[0]
corpus_record_absent
review object · 5 fields
state
partial
machine_critique object · 7 fields
status
passed
providers array · 2 items
[0] object · 7 fields
provider
minimax
model
MiniMax-M3.1-Flash
prompt_version
full-text-reading-v1
prompt_hash
1459cb735852eefdaee36ec1de2ab4851bce10ed2ef4bab1bd35f12ee83262ba
source_hash
670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c
raw_response_sha256
sha256:9d9e740a46f8f9dc42017db9809ded461bceb6928fdc63fefc67f412192a5e5d
raw_response_chars
4637
[1] object · 7 fields
provider
minimax_alt
model
MiniMax-M3
prompt_version
full-text-reading-v1
prompt_hash
fc63ba2c1031fa2a15e156732a8d6c53114f0f6c8faf0b913c82ee20a14e8ddf
source_hash
670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c
raw_response_sha256
sha256:95a80186db95a3d58ae49cef443e58838babac9577f53f2d3a34767fe71f8877
raw_response_chars
76573
target_providers array · 2 items
[0] object · 8 fields
provider
minimax
model
MiniMax-M3.1-Flash
prompt_version
replication-target-v2
prompt_hash
541e969952070f47ba86b0a0b91cc993f56080e6943aa831faa8fb4e3a823e36
source_hash
670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c
raw_response
{"parent_value":21.6,"unit":"%","evidence":"The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall","target_result":"Overall pathological complete response (pCR) rate in the IMPC group","number_stated":true}
reading object · 6 fields
parent_value
21.6
unit
%
evidence
The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall
target_result
Overall pathological complete response (pCR) rate in the IMPC group
number_stated
true
source_locator
chars 1378-1500 of source sha256 670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c
recorded_at
2026-10-31T15:31:05.792505+00:00
[1] object · 8 fields
provider
minimax_alt
model
MiniMax-M3
prompt_version
replication-target-v2
prompt_hash
fd793bc56b78cbe3ff005ab23894642ed569ee6c1021702c12b75200940cf22a
source_hash
670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c
raw_response
<think>We need answer JSON only. Need identify single numerical result headline for registered target main finding. Paper main finding likely pCR rate IMPC vs non-IMPC overall: 21.6% vs 47.1%. Asked "single numerical result" and report headline number only: value paper itself states for registered target, not calculated. Registered target vague "headline numerical result paper states for its main finding." Need choose parent_value likely 21.6, unit %. Evidence exact contiguous quote containing number, whole clause attribution. Could perhaps headline result is pCR rates 21.6% vs 47.1%. But schema singular parent_value. "single numerical result that a replication ... has to reproduce. Report headline number only". The headline number attached to main target likely IMPC pCR overall =21.6%. Need evidence quote clause: "The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall..." This includes comparison, and target. But "headline number only" parent_value 21.6. Unit %. Could target perhaps 21.6% vs 47.1%; "single numerical result" could mean result statement includes pair? Yet schema parent_value numeric only, singular. Usually these tasks ask registered target likely a benchmark value from source, perhaps paper's headline numerical result. Need infer extraction conventions. They say attribution may be carried by parenthetical list, respectively, or direct words. Quote whole clause. Here direct wording identifies "IMPC group" and lower pCR compared to non, then values respectively by order. Headline likely 21.6% for IMPC group. Evidence exact quote. target_result describe. JSON valid, no markdown. Need ensure exact contiguous quotation and not shorten. Could quote: "The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall, 15.0% vs. 28.4% (P = 0.223) in the H-based subgroup, and 27.8% vs. 57.6% (P = 0.017) in the HP-based subgroup." But whole clause enough, yet perhaps to establish "overall" include through "(P = 0.004) overall". Exact contiguous. Evidence contains both values and P; that's okay. Asked headline number only refers output fields likely no extra numerical values in target_result. But evidence necessarily contains numbers plural. Could quote minimal contiguous clause: "The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall" Is that a grammatical exact contiguous quotation? Yes from source before comma. No ellipsis. Attribution clear. Parent_value 21.6. unit "%". target_result maybe "Overall pathological complete response rate in the IMPC group." Avoid numerical mention. number_stated true. Question: "find the single numerical result that a replication of the registered target has to reproduce." Could headline numerical result perhaps 244 patients? Main finding headline is lower pCR, likely 21.6%. Need choose. Let's scrutinize title/abstract. Abstract reports n 244, subgroup counts, pCR 21.6 vs 47.1 overall and subgroups, survival P values, CTNNB1. Which is "headline numerical result"? Usually benchmark questions might target a specific number like "pCR in IMPC group." They registered target generic, no named endpoint, says headline numerical result paper states for its main finding. Main claim resistance, numerical centerpiece pCR rate 21.6%. So yes. Could parent_value perhaps 47.1? Headline "IMPC lower pCR compared to non-IMPC: 21.6% vs 47.1%" and target main finding may be difference? No difference not stated, cannot calculate. User explicitly no calculated. The first number 21.6 is headline for IMPC main finding. Unit printed "%". Evidence should maybe include full sentence as exact contiguous quotation to show attribution. They warn "When that is how the text links them, quote the whole clause so a reader can check the attribution for themselves." Entire clause sentence perhaps. Use entire sentence including subgroup rates. But "Report headline number only" perhaps evidence can contain all, since quote exact and no shortening. They explicitly evidence exact contiguous quote containing number; do not shorten it. "do not shorten it" means likely quote source passage, perhaps whole clause. Let's quote sentence exactly. parent_value only headline number. target_result no other number. JSON string escaping. Ensure unicode okay. Could use β irrelevant. Let's formulate: { "parent_value":21.6, "unit":"%", "evidence":"The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall, 15.0% vs. 28.4% (P = 0.223) in the H-based subgroup, and 27.8% vs. 57.6% (P = 0.017) in the HP-based subgroup.", "target_result":"Overall pathological complete response (pCR) rate in the IMPC group.", "number_stated":true } Does evidence include multiple numbers but okay. Could quote only clause up to overall, but "do not shorten it" suggests full sentence. Good. Need reply JSON object only, no code fence.</think> {"parent_value":21.6,"unit":"%","evidence":"The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall, 15.0% vs. 28.4% (P = 0.223) in the H-based subgroup, and 27.8% vs. 57.6% (P = 0.017) in the HP-based subgroup.","target_result":"Overall pathological complete response (pCR) rate in the IMPC group.","number_stated":true}
reading object · 6 fields
parent_value
21.6
unit
%
evidence
The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall, 15.0% vs. 28.4% (P = 0.223) in the H-based subgroup, and 27.8% vs. 57.6% (P = 0.017) in the HP-based subgroup.
target_result
Overall pathological complete response (pCR) rate in the IMPC group.
number_stated
true
source_locator
chars 1378-1612 of source sha256 670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c
recorded_at
2026-10-31T15:31:07.823079+00:00
agreement
true
disagreements object · 3 fields
target_result object · 3 fields
minimax
The IMPC group had a lower overall pathological complete response rate than the non-IMPC group: 21.6% versus 47.1% (P = 0.004).
minimax_alt
The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall, 15.0% vs. 28.4% (P = 0.223) in the H-based subgroup, and 27.8% vs. 57.6% (P = 0.017) in the HP-based subgroup.
decisive
false
physical_methods object · 3 fields
minimax array · 1 item
[0]
To validate bioinformatics findings, matched pretreatment tumor samples from both groups were analyzed.
minimax_alt array · 2 items
[0]
Validation using matched pretreatment tumor samples from both groups
[1]
Assessment of tumor-infiltrating lymphocytes, CD4+ and CD8+ T cells, M2 macrophages, and PD-L1 expression in matched tumor samples
decisive
false
analysis_methods object · 3 fields
minimax array · 5 items
[0]
Differentially expressed genes (DEGs) were identified using the “limma” R package with criteria of adjusted P-value < 0.05 and |logFC| ≥ 1.
[1]
Enrichment analysis for Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) was performed using “ClusterProfiler” with a significance threshold of corrected P-value < 0.05.
[2]
The protein-protein interaction (PPI) network for Homo sapiens was built using the STRING database with a minimum confidence score of 0.4.
[3]
Hub genes were identified using the CytoHubba plugin with the maximal clique centrality (MCC) algorithm.
[4]
Immune cell abundance was assessed by ImmuCellAI.
minimax_alt array · 7 items
[0]
Retrospective IMPC versus non-IMPC comparison of baseline clinical and pathological characteristics, pCR rates, and survival outcomes
[1]
R v4.0.4 normalization of the GSE66418 gene-expression matrix
[2]
Differential expression analysis using the “limma” R package with adjusted P-value < 0.05 and |logFC| ≥ 1
[3]
KEGG and Gene Ontology enrichment analysis using “ClusterProfiler” with corrected P-value < 0.05
[4]
STRING protein-protein interaction network construction
[5]
Cytoscape and CytoHubba hub-gene identification using the maximal clique centrality algorithm
[6]
Immune-cell abundance assessment using ImmuCellAI
decisive
false
agreement_basis object · 2 fields
policy
decisive_fields
decisive_fields array · 4 items
[0]
work_type
[1]
number_stated
[2]
parent_value
[3]
unit
blinded
true
human_critique object · 5 fields
status
not_run
reviewer
null
signed_at
null
conflict_checked
false
commentary
null
stages array · 7 items
[0] object · 4 fields
key
target_materials
status
pending
reason
null
evidence
null
[1] object · 4 fields
key
independent_readings
status
passed
reason
The independent readings are incomplete or disagree; the source evidence must resolve the difference.
evidence object · 1 field
provider_errors array · 0 items
[2] object · 4 fields
key
source_resolution
status
pending
reason
null
evidence
null
[3] object · 4 fields
key
protocol_reconstruction
status
pending
reason
null
evidence
null
[4] object · 4 fields
key
control_execution
status
pending
reason
null
evidence
null
[5] object · 4 fields
key
control_comparison
status
pending
reason
null
evidence
null
[6] object · 4 fields
key
publication
status
pending
reason
null
evidence
null
gaps array · 2 items
[0]
review.human_critique
[1]
review.machine_critique.passed
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 1 item
[0] object · 3 fields
id
package:79cf8a6ec0adb3b42af8765ed98092924779e0940a2482150906372b550fcfb1
type
sep_package
label
SEP v1 package for pmid:40821778
activities array · 1 item
[0] object · 4 fields
id
activity:conversion:pmid:40821778
type
conversion
used array · 1 item
[0]
package:79cf8a6ec0adb3b42af8765ed98092924779e0940a2482150906372b550fcfb1
agent
agent:corpus-assay-engine
agents array · 3 items
[0] object · 3 fields
id
agent:minimax
type
model
label
minimax
[1] object · 3 fields
id
agent:minimax_alt
type
model
label
minimax_alt
[2] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
source_run_id
run-20261023T122449232913
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:40821778
parent_hash
sha256:df45a341e5b4753af4d79c3e80855932e7126462a57aeb3be880430b909fca26
fork_of
null
gaps array · 13 items
[0]
abstract
[1]
asset:source:pmid:40821778 not verified
[2]
authors
[3]
capability
[4]
corpus_record_absent
[5]
execution.not_run
[6]
method
[7]
review.human_critique
[8]
review.machine_critique.passed
[9]
step:obtain_source_data blocked on data:not_downloaded
[10]
step:run_analysis blocked on no owned computational capability is bound to this experiment
[11]
step:run_analysis input 'materials:the source data behind the published result in pmid:40821778' does not resolve to a declared asset
[12]
targets
Complete file
{"sci_version": "1.0", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:40821778", "kind": "science-record", "revision": 2, "content_hash": "sha256:e234d5a4372b88f404311a019bfcd205525a4495f607cc208c3fdc4e78a88de6", "created_at": "2026-11-01T10:25:52Z", "updated_at": "2026-11-01T14:01:46Z", "generator": {"name": "corpus-assay-engine", "converter": "sep_to_sci_v1", "source_package_schema": "urn:bntrg:sep:1.0.0"}, "paper": {"state": "partial", "title": "HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy.", "doi": "10.3389/fimmu.2025.1623675", "pmid": "40821778", "authors": null, "journal": "Frontiers in immunology", "year": 2025, "abstract": null, "claims": [{"id": "claim-1", "statement": "the headline numerical result the paper states for its main finding", "kind": "quantitative", "state": "complete", "target": {"value": 21.6, "unit": "percent", "tolerance": null, "source": "chars 1378-1500 of source sha256 670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c"}, "evidence": [{"asset": "source:pmid:40821778", "locator": "chars 1378-1500 of source sha256 670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c", "quote": "The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall"}]}], "gaps": ["abstract", "authors"]}, "experiment": {"state": "partial", "objective": "the headline numerical result the paper states for its main finding", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate and its interval from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The number a replication must land on, and the sentence it came from.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:40821778"], "outputs": ["the published estimate, its unit and its interval"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data behind the published result", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:not_downloaded", "description": "The published result cannot be recomputed without the data the paper analysed.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the analysis programme", "kind": "analysis", "state": "blocked", "blocked_on": "no owned computational capability is bound to this experiment", "description": "Re-run the paper's analysis on the source data and produce the registered result. | SEP input not carried into the asset list: materials:the source data behind the published result in pmid:40821778", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the registered result"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:not_downloaded", "step:run_analysis blocked on no owned computational capability is bound to this experiment", "step:run_analysis input 'materials:the source data behind the published result in pmid:40821778' does not resolve to a declared asset"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:40821778", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3389/fimmu.2025.1623675", "sha256": "sha256:670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c", "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3389/fimmu.2025.1623675", "version": null, "note": "Source read by the package builder: full_text.", "structure": {"access_state": "full_text"}}, {"id": "asset:table:pmid:40821778:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:6339ba42bbb813ada8b6205800990e40a75b71c395a70157c0d26a996171d11e", "bytes": 1483, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[9]/table-wrap[1]#T1", "version": null, "note": "Baseline characteristics.", "structure": {"pmcid": "PMC12354535", "section_index": 9, "section_title": "Baseline characteristics", "row_count": 26, "column_count": 5}, "table": {"label": "Table 1", "caption": "Baseline characteristics.", "rows": [["Characteristic", "Total (n = 244)", "IMPC (n = 38)", "Non-IMPC (n = 206)", "aP-value"], ["Median age (year)", "46 (25–74)", "44 (25–66)", "47 (25–74)", "0.133"], ["Age, n (%)", "", "", "", "0.183"], ["≤40", "80 (32.8)", "16 (42.1)", "64 (31.1)", ""], [">40", "164 (67.2)", "22 (57.9)", "142 (68.9)", ""], ["Tumor size, n (%)", "", "", "", "0.748"], ["≤ 2 cm", "20 (8.2)", "2 (5.3)", "18 (8.7)", ""], ["> 2 cm", "224 (91.8)", "36 (94.7)", "188 (91.3)", ""], ["Lymph nodes, n (%)", "", "", "", "0.406"], ["Negative", "12 (4.9)", "3 (7.9)", "9 (4.4)", ""], ["Positive", "232 (95.1)", "35 (92.1)", "197 (95.6)", ""], ["Hormone receptor, n (%)", "", "", "", "<0.05"], ["Negative", "90 (36.9)", "11 (28.9)", "79 (38.3)", ""], ["Positive", "154 (63.1)", "27 (71.1)", "127 (61.7)", ""], ["Grade, n (%)", "", "", "", "0.993"], ["G1 + G2", "135 (55.3)", "21 (55.3)", "114 (55.3)", ""], ["G3", "109 (44.7)", "17 (44.7)", "92 (44.7)", ""], ["Ki-67, n (%)", "", "", "", "0.254"], ["≤30%", "104 (42.6)", "13 (34.2)", "91 (44.2)", ""], [">30%", "140 (57.4)", "25 (65.8)", "115 (55.8)", ""], ["Neoadjuvant targeted therapy, n (%)", "", "", "", "0.052"], ["Trastuzumab", "94 (38.5)", "20 (52.6)", "74 (35.9)", ""], ["Trastuzumab + pertuzumab", "150 (61.5)", "18 (47.4)", "132 (64.1)", ""], ["Neoadjuvant chemotherapy, n (%)"], ["AC-T", "170 (69.7)", "24 (63.2)", "146 (70.9)", "0.342"], ["TCb", "74 (30.3)", "14 (35.8)", "60 (29.1)", ""]], "row_count": 26, "column_count": 5, "numeric_cells": 70, "header_rows": 1, "locator": "section[9]/table-wrap[1]#T1"}}], "gaps": ["asset:source:pmid:40821778 not verified"]}, "analysis": {"state": "absent", "methods": [], "targets": [], "gaps": ["method", "targets"]}, "capability": {"state": "absent", "requirements": [], "gaps": ["capability"]}, "readiness": {"state": "partial", "tier": null, "blocking_axis": null, "blocked_on": null, "axes": {}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:40821778", "asset:table:pmid:40821778:1"], "steps": ["read_published_estimate"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": ["xml"], "capabilities": [], "data_gaps": ["source:pmid:40821778"]}, "gaps": ["corpus_record_absent"]}, "review": {"state": "partial", "machine_critique": {"status": "passed", "providers": [{"provider": "minimax", "model": "MiniMax-M3.1-Flash", "prompt_version": "full-text-reading-v1", "prompt_hash": "1459cb735852eefdaee36ec1de2ab4851bce10ed2ef4bab1bd35f12ee83262ba", "source_hash": "670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c", "raw_response_sha256": "sha256:9d9e740a46f8f9dc42017db9809ded461bceb6928fdc63fefc67f412192a5e5d", "raw_response_chars": 4637}, {"provider": "minimax_alt", "model": "MiniMax-M3", "prompt_version": "full-text-reading-v1", "prompt_hash": "fc63ba2c1031fa2a15e156732a8d6c53114f0f6c8faf0b913c82ee20a14e8ddf", "source_hash": "670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c", "raw_response_sha256": "sha256:95a80186db95a3d58ae49cef443e58838babac9577f53f2d3a34767fe71f8877", "raw_response_chars": 76573}], "target_providers": [{"provider": "minimax", "model": "MiniMax-M3.1-Flash", "prompt_version": "replication-target-v2", "prompt_hash": "541e969952070f47ba86b0a0b91cc993f56080e6943aa831faa8fb4e3a823e36", "source_hash": "670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c", "raw_response": "{\"parent_value\":21.6,\"unit\":\"%\",\"evidence\":\"The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall\",\"target_result\":\"Overall pathological complete response (pCR) rate in the IMPC group\",\"number_stated\":true}", "reading": {"parent_value": 21.6, "unit": "%", "evidence": "The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall", "target_result": "Overall pathological complete response (pCR) rate in the IMPC group", "number_stated": true, "source_locator": "chars 1378-1500 of source sha256 670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c"}, "recorded_at": "2026-10-31T15:31:05.792505+00:00"}, {"provider": "minimax_alt", "model": "MiniMax-M3", "prompt_version": "replication-target-v2", "prompt_hash": "fd793bc56b78cbe3ff005ab23894642ed569ee6c1021702c12b75200940cf22a", "source_hash": "670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c", "raw_response": "<think>We need answer JSON only. Need identify single numerical result headline for registered target main finding. Paper main finding likely pCR rate IMPC vs non-IMPC overall: 21.6% vs 47.1%. Asked \"single numerical result\" and report headline number only: value paper itself states for registered target, not calculated. Registered target vague \"headline numerical result paper states for its main finding.\" Need choose parent_value likely 21.6, unit %. Evidence exact contiguous quote containing number, whole clause attribution. Could perhaps headline result is pCR rates 21.6% vs 47.1%. But schema singular parent_value. \"single numerical result that a replication ... has to reproduce. Report headline number only\". The headline number attached to main target likely IMPC pCR overall =21.6%. Need evidence quote clause: \"The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall...\" This includes comparison, and target. But \"headline number only\" parent_value 21.6. Unit %.\n\nCould target perhaps 21.6% vs 47.1%; \"single numerical result\" could mean result statement includes pair? Yet schema parent_value numeric only, singular. Usually these tasks ask registered target likely a benchmark value from source, perhaps paper's headline numerical result. Need infer extraction conventions. They say attribution may be carried by parenthetical list, respectively, or direct words. Quote whole clause. Here direct wording identifies \"IMPC group\" and lower pCR compared to non, then values respectively by order. Headline likely 21.6% for IMPC group. Evidence exact quote. target_result describe. JSON valid, no markdown.\n\nNeed ensure exact contiguous quotation and not shorten. Could quote: \"The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall, 15.0% vs. 28.4% (P = 0.223) in the H-based subgroup, and 27.8% vs. 57.6% (P = 0.017) in the HP-based subgroup.\" But whole clause enough, yet perhaps to establish \"overall\" include through \"(P = 0.004) overall\". Exact contiguous. Evidence contains both values and P; that's okay. Asked headline number only refers output fields likely no extra numerical values in target_result. But evidence necessarily contains numbers plural. Could quote minimal contiguous clause: \"The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall\" Is that a grammatical exact contiguous quotation? Yes from source before comma. No ellipsis. Attribution clear. Parent_value 21.6. unit \"%\". target_result maybe \"Overall pathological complete response rate in the IMPC group.\" Avoid numerical mention. number_stated true.\n\nQuestion: \"find the single numerical result that a replication of the registered target has to reproduce.\" Could headline numerical result perhaps 244 patients? Main finding headline is lower pCR, likely 21.6%. Need choose. Let's scrutinize title/abstract. Abstract reports n 244, subgroup counts, pCR 21.6 vs 47.1 overall and subgroups, survival P values, CTNNB1. Which is \"headline numerical result\"? Usually benchmark questions might target a specific number like \"pCR in IMPC group.\" They registered target generic, no named endpoint, says headline numerical result paper states for its main finding. Main claim resistance, numerical centerpiece pCR rate 21.6%. So yes.\n\nCould parent_value perhaps 47.1? Headline \"IMPC lower pCR compared to non-IMPC: 21.6% vs 47.1%\" and target main finding may be difference? No difference not stated, cannot calculate. User explicitly no calculated. The first number 21.6 is headline for IMPC main finding. Unit printed \"%\". Evidence should maybe include full sentence as exact contiguous quotation to show attribution. They warn \"When that is how the text links them, quote the whole clause so a reader can check the attribution for themselves.\" Entire clause sentence perhaps. Use entire sentence including subgroup rates. But \"Report headline number only\" perhaps evidence can contain all, since quote exact and no shortening. They explicitly evidence exact contiguous quote containing number; do not shorten it. \"do not shorten it\" means likely quote source passage, perhaps whole clause. Let's quote sentence exactly. parent_value only headline number. target_result no other number.\n\nJSON string escaping. Ensure unicode okay. Could use β irrelevant.\n\nLet's formulate:\n{\n \"parent_value\":21.6,\n \"unit\":\"%\",\n \"evidence\":\"The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall, 15.0% vs. 28.4% (P = 0.223) in the H-based subgroup, and 27.8% vs. 57.6% (P = 0.017) in the HP-based subgroup.\",\n \"target_result\":\"Overall pathological complete response (pCR) rate in the IMPC group.\",\n \"number_stated\":true\n}\n\nDoes evidence include multiple numbers but okay. Could quote only clause up to overall, but \"do not shorten it\" suggests full sentence. Good.\n\nNeed reply JSON object only, no code fence.</think>\n\n{\"parent_value\":21.6,\"unit\":\"%\",\"evidence\":\"The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall, 15.0% vs. 28.4% (P = 0.223) in the H-based subgroup, and 27.8% vs. 57.6% (P = 0.017) in the HP-based subgroup.\",\"target_result\":\"Overall pathological complete response (pCR) rate in the IMPC group.\",\"number_stated\":true}", "reading": {"parent_value": 21.6, "unit": "%", "evidence": "The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall, 15.0% vs. 28.4% (P = 0.223) in the H-based subgroup, and 27.8% vs. 57.6% (P = 0.017) in the HP-based subgroup.", "target_result": "Overall pathological complete response (pCR) rate in the IMPC group.", "number_stated": true, "source_locator": "chars 1378-1612 of source sha256 670d0f3c400a9ec12fb132f47497827e1c8a2a6491abae3fa5b9d9322491647c"}, "recorded_at": "2026-10-31T15:31:07.823079+00:00"}], "agreement": true, "disagreements": {"target_result": {"minimax": "The IMPC group had a lower overall pathological complete response rate than the non-IMPC group: 21.6% versus 47.1% (P = 0.004).", "minimax_alt": "The IMPC group exhibited significantly lower pCR rates compared to the non-IMPC group: 21.6% vs. 47.1% (P = 0.004) overall, 15.0% vs. 28.4% (P = 0.223) in the H-based subgroup, and 27.8% vs. 57.6% (P = 0.017) in the HP-based subgroup.", "decisive": false}, "physical_methods": {"minimax": ["To validate bioinformatics findings, matched pretreatment tumor samples from both groups were analyzed."], "minimax_alt": ["Validation using matched pretreatment tumor samples from both groups", "Assessment of tumor-infiltrating lymphocytes, CD4+ and CD8+ T cells, M2 macrophages, and PD-L1 expression in matched tumor samples"], "decisive": false}, "analysis_methods": {"minimax": ["Differentially expressed genes (DEGs) were identified using the “limma” R package with criteria of adjusted P-value < 0.05 and |logFC| ≥ 1.", "Enrichment analysis for Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) was performed using “ClusterProfiler” with a significance threshold of corrected P-value < 0.05.", "The protein-protein interaction (PPI) network for Homo sapiens was built using the STRING database with a minimum confidence score of 0.4.", "Hub genes were identified using the CytoHubba plugin with the maximal clique centrality (MCC) algorithm.", "Immune cell abundance was assessed by ImmuCellAI."], "minimax_alt": ["Retrospective IMPC versus non-IMPC comparison of baseline clinical and pathological characteristics, pCR rates, and survival outcomes", "R v4.0.4 normalization of the GSE66418 gene-expression matrix", "Differential expression analysis using the “limma” R package with adjusted P-value < 0.05 and |logFC| ≥ 1", "KEGG and Gene Ontology enrichment analysis using “ClusterProfiler” with corrected P-value < 0.05", "STRING protein-protein interaction network construction", "Cytoscape and CytoHubba hub-gene identification using the maximal clique centrality algorithm", "Immune-cell abundance assessment using ImmuCellAI"], "decisive": false}}, "agreement_basis": {"policy": "decisive_fields", "decisive_fields": ["work_type", "number_stated", "parent_value", "unit"]}, "blinded": true}, "human_critique": {"status": "not_run", "reviewer": null, "signed_at": null, "conflict_checked": false, "commentary": null}, "stages": [{"key": "target_materials", "status": "pending", "reason": null, "evidence": null}, {"key": "independent_readings", "status": "passed", "reason": "The independent readings are incomplete or disagree; the source evidence must resolve the difference.", "evidence": {"provider_errors": []}}, {"key": "source_resolution", "status": "pending", "reason": null, "evidence": null}, {"key": "protocol_reconstruction", "status": "pending", "reason": null, "evidence": null}, {"key": "control_execution", "status": "pending", "reason": null, "evidence": null}, {"key": "control_comparison", "status": "pending", "reason": null, "evidence": null}, {"key": "publication", "status": "pending", "reason": null, "evidence": null}], "gaps": ["review.human_critique", "review.machine_critique.passed"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "package:79cf8a6ec0adb3b42af8765ed98092924779e0940a2482150906372b550fcfb1", "type": "sep_package", "label": "SEP v1 package for pmid:40821778"}], "activities": [{"id": "activity:conversion:pmid:40821778", "type": "conversion", "used": ["package:79cf8a6ec0adb3b42af8765ed98092924779e0940a2482150906372b550fcfb1"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:minimax", "type": "model", "label": "minimax"}, {"id": "agent:minimax_alt", "type": "model", "label": "minimax_alt"}, {"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}], "source_run_id": "run-20261023T122449232913", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:40821778", "parent_hash": "sha256:df45a341e5b4753af4d79c3e80855932e7126462a57aeb3be880430b909fca26", "fork_of": null, "generation": 2}, "gaps": ["abstract", "asset:source:pmid:40821778 not verified", "authors", "capability", "corpus_record_absent", "execution.not_run", "method", "review.human_critique", "review.machine_critique.passed", "step:obtain_source_data blocked on data:not_downloaded", "step:run_analysis blocked on no owned computational capability is bound to this experiment", "step:run_analysis input 'materials:the source data behind the published result in pmid:40821778' does not resolve to a declared asset", "targets"]}